YANKO ENAMORADO: Open Payments
NPI 1578905501 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,557 in 103 payments from 13 companies in 2025. Trend: 2023 $2,720 · 2024 $2,365 · 2025 $2,557
Food & beverage: $2,557
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $451 |
| Janssen Pharmaceuticals, Inc | 18 | $424 |
| Alkermes, Inc. | 9 | $311 |
| E.R. Squibb & Sons, L.L.C. | 11 | $301 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $227 |
| Lundbeck LLC | 9 | $183 |
| Vanda Pharmaceuticals Inc. | 7 | $181 |
| Axsome Therapeutics, Inc. | 6 | $161 |
| ABBVIE INC. | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
Products named: UZEDY, INVEGA SUSTENNA, COBENFY, REXULTI, CAPLYTA, ARISTADA, Auvelity, LYBALVI.
Industry payments across FL — which companies pay providers there.
